CYP4B1 and laryngotracheoesophageal cleft: These findings demonstrate the critical role of the NNK‐induced 1p‐Enh/CYP4B1 regulatory axis in both HF and LC, suggesting that CYP4B1 may serve as a potential therapeutic target for the concurrent treatment of HF and LC.